Citations 1
Results of real-time cell-of-origin subtype identification by gene expression profiling in patients with ABC-type diffuse large B-cell lymphoma in the phase III trial of lenalidomide plus R-CHOP vs placebo plus R-CHOP (ROBUST).
Nowakowski, Grzegorz S. , Chiappella, Annalisa , Spina, Michele , Gascoyne, Randy D. , Russo, Jacqueline, Kang, Janet, Zhang, Jingshan , Xu, Yingyong, investigators, on behalf of the ROBUST study, Witzig, Thomas E. , Scott, David W. , Zhang, Lei , Vitolo, Umberto , investigators, on behalf of the ROBUST study
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 7548-7548
